The discovery made by the Official State Experience
02/28/2019 06h – Douradosnews
Experts from the Institute of Forensic Laboratory Analysis (Ialf) have identified 22 new types of drugs circulating in Mato Grosso do Sul between 2017 and 2018. This number rises to 34 if the team is considered to have made the first identification in 2014.
The discovery made by the State Official Expertise on this new activity of traffickers still has repercussions at the national level, with the National Agency for Sanitary Surveillance (Anvisa), including narcotics in an alert list for the authorities throughout Brazil and who continue to report to international institutions.
The new drugs have been identified as ADB-Fubinaca (from the synthetic cannabinoid group); 4-Fluoro-PHP, Dibutylone, MDPPP and N-Ethylpentylone (Ephilone) – which are from the synthetic catinone group -; 25B-NBOMe, 25E-NBOH, 25I-NBH, 25I-NBOH, 25I-NBOMe, 25C-B, 20C-I, DOC (of the phenylethylamine group ); DMT, MIPT and N, N-Dimethyltryptamine (from the tryptamine group); in addition to Fentanyl and Furanilfentanil (other psychedelic, opiate, sedative / hypnotic, stimulant substances).
The contribution of the Ialf team was included in the report of activities of the Working Group on classification of controlled substances 2017/2018, published on February 15 of this year.
The new psychoactive substances (NSP) identified in Mato Grosso do Sul have been seized in various actions of the Civil, Military and DoF (Department of Frontier Operations).
The identification of these NSPs is based on the regulations of the United Nations Office on Drugs and Crimes (UNODC).
"They are substances of abuse, either purely or as part of a mixture, that are not controlled internationally by the Single Convention on Phytosanitary Drugs (1961) or by the Convention on Psychotropic Substances (1971), but may pose a threat to public health ", specifies the Anvisa report.
Almost 70% of these new substances were discovered between 2013 and 2017.
In Brazil, the illegal market focuses on phenylethylamines, synthetic cannabinoids, synthetic catinones, triptins, phyciclidines, plant substances and other substances (opiates, sedatives / hypnotics, classical stimulants and hallucinogens).
The use of these new drugs can cause convulsions, agitation, aggression, acute psychosis, addiction development and even death. Studies are still underway to try to identify the risk potential for cancer and the level of toxicity of these new drugs. "The identity of the drug consumed is sometimes unknown or masked, leading to unpredictable effects," says the National Agency for Health Surveillance. The result of it in public health is urgent assistance in hospitals.